Lurie Cancer Center
@LurieCancer
Followers
10K
Following
29K
Media
3K
Statuses
19K
Cancer program @NorthwesternMed. Northwestern Memorial Hospital is among top 2% of hospitals in the nation for cancer by U.S. News & World Report, 2025 – 2026.
Chicago, IL
Joined December 2012
Thank you very much, Ali! Honored and humbled to be named Thomas D. Spies Professor of Genetic Metabolism. Thanks to @ShilatifardLab @NUFeinbergMed @LurieCancer, mentors @frederic_bost, Brendan Manning, NoTwitterNav, my family & friends!
Congratulations to my colleague & friend from the Department of Biochemistry & Molecular Genetics, Dr. Issam Ben-Sahra, @bensahralab on being honored with the Thomas D. Spies Professor of Genetic Metabolism endowed professorship at @NUFeinbergMed. This is a well-deserved
21
4
76
Congratulations to Lurie Cancer Center member Yogesh Goyal, PhD, on being named an Edward Mallinckrodt, Jr. Foundation Grant Fellow! The award will enable his interdisciplinary research group to “follow promising leads wherever they may take us.” Read more:
1
1
7
#ClinicalTrial MM1OA-EA02, led by @jaltmanmd of @LurieCancer, aims to improve results for older adults with #AcuteMyeloidLeukemia (#AML). Learn more: https://t.co/lqKwON7qZ1
#BloodCancer #leukemia
0
1
2
Hanging out in San Diego today and tomorrow? Come join us at #NCCNhem25 annual meeting! Outstanding first session on care coordination with community and academic practices. @DanPollyea @Daver_Leukemia
0
3
14
“This trial could redefine how genetic services are delivered in community settings and improve outcomes for the many thousands of #AYAcancer survivors who can expect to live decades beyond their initial diagnosis and recovery,” said @LurieCancer member Tara Henderson, MD, PhD,
New study to determine whether chatbot #technology and digital tools can promote access to life-saving genetic counseling for young cancer survivors. https://t.co/whn8NOYFvM
#pediatrics #research #healthtechnology
0
0
2
Dear .NET community Announcing our official collaboration with Microsoft! We’re stepping up our contributions to @dotnet - helping advance the ecosystem as a whole. We're announcing the 1st step today, alongside .NET 10 RC2 - collaboration with the .NET MAUI team to keep
23
64
279
Have you registered for the @ALLIANCE_org Fall Group Meeting in Chicago taking place November 5-7? Registration is open to attend virtually or in person. Visit https://t.co/8jgQPv5RPi to register. #AllianceFall25 #NCI #NCTN #NCORP #CancerResearch
0
2
6
A call-to-action for the scientific community by Lurie Cancer Center member @CHADNANO @IINanoNU and collaborators: 33 Unresolved Questions in #Nanoscience and #Nanotechnology
https://t.co/cldHACwN0N? Via ACS Nano @ACSPublications #NationalNanoDay @NUFeinbergMed
pubs.acs.org
Significant advances in science and engineering often emerge at the intersections of disciplines. Nanoscience and nanotechnology are inherently interdisciplinary, uniting researchers from chemistry,...
1
0
2
In Baltimore, at the Johns Hopkins Cancer Center advisory board, with my good friend @KunleOdunsiMD, Director of the University of Chicago Cancer Center. Discussing future collaborations between our centers in Chicago! @LurieCancer
2
3
25
Lurie Cancer Center’s @DrWGradishar, Chair of the NCCN #BreastCancer Guidelines Panel, discusses the new NCCN Guidelines Navigator for Breast Cancer #GeneticTesting and Treatment — and its potential for improving care. https://t.co/QvNkD8u7mf
#BreastCancerAwarenessMonth #BCSM
0
0
3
Providing hope for liver metastasis from ocular melanoma. #ophthalmology #eyecancer #Ophthotwitter #uvealmelanoma
https://t.co/2QtnxvBfaX
news.nm.org
A new treatment for stage IV uveal melanoma delivers chemotherapy directly to the liver, minimizing side effects and reducing the drug’s impact on other parts of the body
0
1
2
Incredible job by Krishay Sridalla, just a 2nd-year medical student, who delivered a beautifully executed presentation at #ACSCC25. Proud to see him highlight our ctDNA results in the High-Impact Clinical Trials Session 👏!! @NMSurgery @NUFeinbergMed @LurieCancer #ChawlaLab
0
2
22
At the Feinberg School of Medicine Investiture Ceremony, with two great leaders of @LurieCancer who were honorees. With @skmaithel, Chief Surgical Officer of @LurieCancer and head of Surgical Oncology; and H. Munshi, Chief of Hematology-Oncology.
0
2
24
A new study by @SusanQuaggin, @hmaekawa0520 and colleagues in @jclinicalinvest revealed SGLT2 inhibition protects kidney function by SAM-dependent #epigenetic repression of inflammatory genes under metabolic stress https://t.co/QmptmoqXsY
0
13
43
.@immunosarc of @LurieCancer is leading EA7222, a randomized phase 3 trial of doxorubicin alone or in combination with pembrolizumab in patients with advanced UPS and related poorly differentiated #sarcomas. More here: https://t.co/KtdZ47T1GZ cc: @CureSarcoma
0
1
1
Northwestern scientists have identified new molecular mechanisms that help specialized #TCells maintain long-term #immunity in response to chronic infection and #cancer, per @NatImmunol.
news.feinberg.northwestern.edu
Scientists in the laboratory of Weiguo Cui, PhD, have identified novel molecular mechanisms that help specialized T-cells maintain long-term immunity in response to chronic infection and cancer,...
2
1
2
Beautiful event and award presentation ceremony tonight -- the 4th annual @LurieCancer Associate Board Summer Cocktail Reception. I was in attendance as a representative of a collaborative team involving my group and the group of Prof. @CraigHorbinski (Department of Pathology
0
2
18
Opening the meeting of the incredible Associate Board of the @LurieCancer center tonight. So grateful for their amazing efforts raising funds for innovative cancer research at Northwestern.
2
1
16
Novel biological markers may help predict which patients will benefit most from specific therapies to treat #prostatecancer, according to a study co-authored by @EdwardSchaeffer, published in @CellCellPress. https://t.co/FJYuetMBYA via @NUFeinbergMed #pcsm
news.feinberg.northwestern.edu
Biological markers may help predict which patients will benefit most from specific therapies to treat prostate cancer, according to a study published in the journal Cell.
0
3
5